Development of Quality Indicators to Evaluate the Appropriateness of Empiric Antimicrobial Use in Pediatric Patients

Holly MacKinnon1, Kathryn Slayter2, Jeannette L Comeau3

  • 1, BScPharm, was, at the time of this study, with Dalhousie University and IWK Health, Halifax, Nova Scotia. She has now graduated and works with Lawtons Drugs.

Insights

Consensus was reached on 28 quality indicators for appropriate empiric antimicrobial use in pediatric inpatients. These indicators help assess antimicrobial prescribing quality and adherence to best practices.

Area of Science:

  • Pediatric infectious diseases
  • Antimicrobial stewardship
  • Health services research

Background:

  • Assessing antimicrobial prescribing in pediatric inpatients is crucial.
  • Quality indicators are recommended for evaluating antimicrobial use.
  • Appropriate antimicrobial prescribing impacts patient outcomes and resistance.

Purpose of the Study:

  • To achieve consensus among infectious diseases clinicians on quality indicators.
  • To define indicators for appropriate empiric antimicrobial use in pediatric inpatients.
  • To establish a benchmark for assessing antimicrobial stewardship.

Main Methods:

  • The Delphi technique was employed to reach expert consensus.
  • An initial list of quality indicators was developed from a literature search.
  • A multidisciplinary panel of experts rated indicators using a 9-point Likert scale.

Main Results:

  • Consensus was achieved on 28 of 31 proposed quality indicators after three rounds.
  • Indicators were categorized into empiric choice, dose, duration, administration, diagnosis, and documentation.
  • Twelve experts completed the survey, with 10 finishing all rounds.

Conclusions:

  • Consensus-based quality indicators were established for empiric antimicrobial use in pediatric patients.
  • These indicators can be utilized by clinicians and researchers to evaluate prescribing practices.
  • The developed indicators support adherence to best practices in pediatric antimicrobial stewardship.
Abstract

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
117
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.7K
Antibiotic Selection00:57

Antibiotic Selection

Overview
54.9K
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
80
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
943